Seattle, WA – InduPro Inc. has announced the appointment of Amanda Redig as Chief Medical Officer. About InduPro Inc.: InduPro Inc. is a biotechnology company focused on defining and harnessing protein spatial relationships and proximity biology to create novel therapeutics for the treatment of cancer and autoimmune diseases. The companys science centers on bringing proteins on the cell surface closer together to manipulate their interactions, enabling a new class of proximity-based therapeutics that modulate disease biology in innovative ways. Using biologics-driven, induced proximity approaches across a broad range of signaling pathways, receptor classes, and membrane-associated targets, InduPro is building a differentiated pipeline of first- and best-in-class drug programs. Its strategy leverages both inherent and induced proximity to discover and develop next-generation therapeutics, including bispecific antibodies and related modalities, positioning the company at the forefront of emerging proximity-based drug design. InduPro operates from sites in Seattle, Washington, and Cambridge, Massachusetts, and brings together a multidisciplinary team with deep pharma, academic, and biotech experience in drug discovery, protein engineering, receptor signaling, and protein interactions to advance life-changing medicines.

For more information visit: https://www.induprotx.com/

InduPro Inc.
1930 Boren Ave Suite 200
Seattle, WA 98101
Phone: 206-593-5005
LinkedIn: https://www.linkedin.com/company/induprotx/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved